Rchr
J-GLOBAL ID：201701016110068845
Update date: May. 17, 2024
Fujiwara Kei
Fujiwara Kei
Affiliation and department：
Job title：
Associate Professor
Research field (1)：
Gastroenterology
Research theme for competitive and other funds (3)：
- 2019 - 2023 HBV遺伝子のヒト遺伝子への組み込みに対する統合的遺伝子解析から肝発癌を予測する
- 2013 - 2017 Development of method to detect four mRNAs of hepatitis B virus in liver tissue
- 2012 - 2016 The new therapy of liver cirrhosis which inhibit the progression fibrosis
Papers (88)：
-
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Kyoko Ito, Shintaro Ogawa, Hayato Kawamura, Kei Fujiwara, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, et al. MicroRNA-223-3p levels in serum-derived extracellular vesicles predict regression of M2BPGi-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents. Journal of gastroenterology. 2024
-
Hayato Kawamura, Kentaro Matsuura, Koichi Ito, Tokio Sugiura, Takanori Suzuki, Kei Fujiwara, Hiromi Kataoka, Yasuhito Tanaka. Efficacy of antiviral therapy for the prevention of mother-to-child transmission of hepatitis B virus and the risk of postpartum hepatitis flare after discontinuation of antiviral therapy. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
-
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Daisuke Kato, Atsunori Kusakabe, Hiroki Koguchi, Izumi Hasegawa, et al. Prognostic Nutritional Index after Introduction of Atezolizumab with Bevacizumab Predicts Prognosis in Advanced Hepatocellular Carcinoma: A Multicenter Study. Oncology. 2024. 1-12
-
Takanori Suzuki, Kentaro Matsuura, Yoshihito Nagura, Hayato Kawamura, Kei Fujiwara, Shintaro Ogawa, Katsuya Nagaoka, Etsuko Iio, Takehisa Watanabe, Hiromi Kataoka, et al. Serum angiopoietin-2 levels predict the development of hepatocellular carcinoma following hepatitis C virus eradication using direct-acting antiviral agents. Oncology. 2024
-
Takanori Suzuki, Kentaro Matsuura, Yuta Suzuki, Fumihiro Okumura, Yoshihito Nagura, Satoshi Sobue, Sho Matoya, Tomokatsu Miyaki, Yoshihide Kimura, Atsunori Kusakabe, et al. Serum CXCL10 levels at the start of the second course of atezolizumab plus bevacizumab therapy predict therapeutic efficacy in patients with advanced BCLC stage C hepatocellular carcinoma: A multicenter analysis. Cancer medicine. 2023
ｍore...
MISC (49)：
-
伊藤 千恵子, 古田 隆子, 井上 貴子, 松浦 健太郎, 藤原 圭. 当院における肝疾患相談室の活動報告と課題. 日本消化器病学会雑誌. 2021. 118. 臨増総会. A262-A262
-
井上貴子, 守屋圭, 瓦谷英人, 飯尾悦子, 松浦健太郎, 藤原圭, 吉治仁志, 田中靖人. C型肝炎ウイルス排除後の糖代謝に関与する腸内フローラの特徴. 糖尿病(Web). 2021. 64. Suppl
-
MURAYAMA Asako, FUJIWARA Kei, YAMADA Norie, SHIINA Masaaki, MURAMATSU Masamichi, WAKITA Takaji, KATO Takanobu. Antiviral effects of second-generation N55A inhibition evaluated in Hepatitis C virus cell culture system with full-genome infectious clones. 日本ウイルス学会学術集会プログラム・抄録集. 2018. 66th. 229-603A
-
村山 麻子, 山田 典栄, 藤原 圭, 村松 正道, 脇田 隆字, 加藤 孝宣. HCV細胞培養系を用いた第二世代NS5A阻害剤の抗ウイルス活性と薬剤耐性変異の解析. 肝臓. 2018. 59. Suppl.1. A319-A319
-
Kei Fujiwara, Kentaro Matsuura, Kayoko Matsunami, Etsuko Iio, Shunsuke Nojiri, Takashi Joh. Novel non-canonical genetic rearrangements termed "complex structural variations" in HBV genome. HEPATOLOGY. 2017. 66. 805A-805A
ｍore...
Books (3)：
-
Human Viruses: Diseases, Treatments and Vaccines
Springer International Publishing 2021
-
がん治療のフロンティア
中日新聞社 2020 ISBN:9784806207719
-
ウイルス肝炎update
中外医学社 2005 ISBN:4498042905
Lectures and oral presentations (9)：
-
B型肝炎
(令和5 年度愛知県肝疾患診療連携拠点病院・専門医療機関等連絡協議会(兼 愛知県肝炎診療従事者等研修会) 2024)
-
L’interféron pégylé réduit les rechutes après traitement par Bepirovirsen chez les patients atteints d’une infection chronique par le virus de l’hépatite B sous analogues nucléos(t)idiques : résultats de fin de l’étude de phase 2b B-Together
(Societe Nationale Francaise de Gastro-Enterologie - JFHOD 2024)
-
Pegylated interferon reduces relapses following bepirovirsen treatment in participants with chronic hepatitis B virus infection on nucleos(t)ide analogs: end of study results from the Phase 2b B-Together study
(AASLD The Liver Meeting 2023 2023)
-
肝硬変の最新治療
(令和4年度愛知県肝疾患診療連携拠点病院・専門医療機関等連絡協議会(兼 愛知県肝炎診療従事者等研修会) 2023)
-
原因不明の肝障害・肝乏血性腫瘤の精査で判明した成人発症 2 型シトルリン血症の 1 例
(日本内科学会東海支部主催第249回 東海地方会 (JP タワー名古屋 ホール&カンファレンス・Web) 2023)
ｍore...
Professional career (2)：
- MD (Nagoya City University)
- PhD (Nagoya City University Graduate School of Medical Sciences)
Committee career (1)：
- 2020/06 - 現在 愛知県肝炎診療協議会 委員
Awards (1)：
- 2013/10 - The Japan Society of Hepatology Crown Award, 6th CHUGAI Award
Return to Previous Page
